Mizuho Maintains Buy on Immunocore Hldgs, Lowers Price Target to $88
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Graig Suvannavejh maintains a Buy rating on Immunocore Holdings (IMCR) but lowers the price target from $90 to $88.

May 13, 2024 | 1:47 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Mizuho maintains a Buy rating on Immunocore Holdings but lowers the price target from $90 to $88.
While the reduction in price target could suggest a slight adjustment in valuation expectations, the maintenance of a Buy rating indicates a continued positive outlook on the company's fundamentals. This mixed signal could lead to a neutral short-term impact on IMCR's stock price, as the market digests both the positive endorsement and the tempered price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100